Taking aspirin daily reduces breast cancer

Science Daily published a study done by the US research team who conducted a study on 127,000 womens and found that aspirin can reduce the risk of breast cancer in women with estrogen receptor positive cancer (ERP+). The study showed that Aspirin reduced the risk of cancer by 16%.

It is feasible, in theory, that aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) could lower the total risk of breast cancer. They block an enzyme called cyclooxygenase, an activity that could disrupt breast cancer development in a number of ways -- for example, by reducing the amount of estrogen produced in the body.

Overall the results were not astonishing, but it appeared that aspirin offered some protection for estrogen eeceptor positive breast cancer.